Aims: Recently, drug-eluting stents (DESs) have been widely adopted for patients on chronic hemodialysis (HD). However, whether DES implantation is associated with a reduced rate of in-stent restenosis (ISR) is unclear. We investigated the incidence of ISR and its predictors in patients on HD after DES implantation. Methods and Results: We analyzed 194 consecutive patients (331 lesions) on HD who underwent follow-up angiography after DES implantation. ISR was observed in 74 lesions (22.4%). Angiographically, the relative incidence of AHA/ACC type C lesion was increased (47 vs. 32%; p = 0.043), the minimal lumen diameter (MLD) before DES implantation was smaller (0.82 ± 0.49 vs. 0.97 ± 0.45 mm; p < 0.01), and the lesion length (LL) was increased (30.2 ± 16.1 vs. 24.4 ± 12.1 mm; p = 0.023) in lesions with ISR compared to those without ISR. The rate of rotational atherectomy use was also increased in lesions with ISR compared to those without ISR (50% vs. 25%; p < 0.01). In a multivariate analysis, the MLD before DES implantation (odds ratio [OR] = 0.50, 95% confidence interval [CI] 0.27–0.91, p = 0.024), LL (OR = 1.02, 95% CI 1.00–1.04, p = 0.030) and the use of rotational atherectomy (OR = 2.71, 95% CI 1.55–4.72, p < 0.01) were independent predictors of ISR. The incidence of ISR was similar between lesions treated with the first-generation (25.8%) and the second-generation DESs (20.4%). Conclusions: ISR was observed in 74 lesions (22.4%). A small MLD, long LL, and the use of rotational atherectomy were independent predictors of ISR after DES implantation in patients on HD. There was no significant difference in the ISR rate between the first- and the second-generation DESs.

1.
Herzog
CA
,
Ma
JZ
,
Collins
AJ
.
Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
.
N Engl J Med
.
1998
;
339
:
799
805
. .
2.
Herzog
CA
,
Ma
JZ
,
Collins
AJ
.
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures
.
Kidney Int
.
1999
;
56
:
324
32
. .
3.
Herzog
CA
,
Littrell
K
,
Arko
C
,
Frederick
PD
,
Blaney
M
.
Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States renal data system and the National registry of myocardial infarction
.
Circulation
.
2007
;
116
:
1465
72
. .
4.
Yasuda
K
,
Kasuga
H
,
Aoyama
T
,
Takahashi
H
,
Toriyama
T
,
Kawade
Y
,
Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients
.
J Am Soc Nephrol
.
2006
;
17
:
2322
32
. .
5.
Hemmelgarn
BR
,
Ghali
WA
,
Quan
H
,
Brant
R
,
Norris
CM
,
Taub
KJ
,
Poor long-term survival after coronary angiography in patients with renal insufficiency
.
Am J Kidney Dis
.
2001
;
37
:
64
72
. .
6.
Bangalore
S
,
Kumar
S
,
Fusaro
M
,
Amoroso
N
,
Attubato
MJ
,
Bhatt
DL
,
Short and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117,762 patient-years of follow-up from randomized trials
.
Circulation
.
2012
;
125
:
2873
91
.
7.
Garg
P
,
Charytan
DM
,
Novack
L
,
Cutlip
DE
,
Popma
JJ
,
Moses
J
,
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials)
.
Am J Cardiol
.
2010
;
106
:
1436
42
. .
8.
Navarese
EP
,
Kowalewski
M
,
Kandzari
D
,
Lansky
A
,
Górny
B
,
Kołtowski
L
,
First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomized clinical trials comprising 31,379 patients
.
Open Heart
.
2014
;
1
(
1
):
e000064
.
9.
Mauri
L
,
Hsieh
WH
,
Massaro
JM
,
Ho
KK
,
D'Agostino
R
,
Cutlip
DE
.
Stent thrombosis in randomized clinical trials of drug-eluting stents
.
N Engl J Med
.
2007
;
356
:
1020
9
. .
10.
Ellis
SG
,
Vandormael
MG
,
Cowley
MJ
,
DiSciascio
G
,
Deligonul
U
,
Topol
EJ
,
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Multivessel angioplasty prognosis study group
.
Circulation
.
1990
;
82
:
1193
202
.
11.
Ting
HH
,
Tahirkheli
NK
,
Berger
PB
,
McCarthy
JT
,
Timimi
FK
,
Mathew
V
,
Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure
.
Am J Cardiol
.
2001
;
87
:
630
A9
. .
12.
Ishio
N
,
Kobayashi
Y
,
Takebayashi
H
,
Iijima
Y
,
Kanda
J
,
Nakayama
T
,
Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients
.
Circ J
.
2007
;
71
:
1525
9
. .
13.
Okada
T
,
Hayashi
Y
,
Toyofuku
M
,
Imazu
M
,
Otsuka
M
,
Sakuma
T
,
One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents
.
Circ J
.
2008
;
72
:
1430
5
. .
14.
Aoyama
T
,
Ishii
H
,
Toriyama
T
,
Takahashi
H
,
Kasuga
H
,
Murakami
R
,
Sirolimus-eluting stents versus bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis
.
Circ J
.
2008
;
72
:
56
60
. .
15.
Yachi
S
,
Tanabe
K
,
Tanimoto
S
,
Aoki
J
,
Nakazawa
G
,
Yamamoto
H
,
Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients
.
Am J Kidney Dis
.
2009
;
54
:
299
306
. .
16.
Ichimoto
E
,
Kobayashi
Y
,
Iijima
Y
,
Kuroda
N
,
Kohno
Y
,
Komuro
I
.
Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients
.
Int Heart J
.
2010
;
51
:
92
7
. .
17.
Higashitani
M
,
Mori
F
,
Yamada
N
,
Arashi
H
,
Kojika
A
,
Hoshi
H
,
Efficacy of Paclitaxel-eluting stent implantation in hemodialysis patients
.
Heart Vessels
.
2011
;
26
:
582
9
. .
18.
Sakakibara
T
,
Ishii
H
,
Toriyama
T
,
Aoyama
T
,
Takahashi
H
,
Kamoi
D
,
Sirolimus-eluting stent versus everolimus-eluting stent for coronary intervention in patients on chronic hemodialysis
.
Circ J
.
2012
;
76
:
351
5
. .
19.
Ikari
Y
,
Tanabe
K
,
Koyama
Y
,
Kozuma
K
,
Sano
K
,
Isshiki
T
,
Sirolimus eluting coronary stent implantation in patients on maintenance hemodialysis: the OUCH study (outcome of cypher stent inhemodialysis patients)
.
Circ J
.
2012
;
76
:
1856
63
. .
20.
Ikari
Y
,
Kyono
H
,
Isshiki
T
,
Ishizuka
S
,
Nasu
K
,
Sano
K
,
Usefulness of everolimus-eluting coronary stent implantation in patients on maintenance hemodialysis
.
Am J Cardiol
.
2015
;
116
(
6
):
872
6
. .
21.
Tanabe
K
,
Kishi
S
,
Aoki
J
,
Tanimoto
S
,
Onuma
Y
,
Yachi
S
,
Impact of coronary calcium on outcome following sirolimus-eluting stent implantation
.
Am J Cardiol
.
2011
;
108
(
4
):
514
7
. .
22.
Hoffmann
R
,
Mintz
GS
,
Mehran
R
,
Kent
KM
,
Pichard
AD
,
Satler
LF
,
Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique
.
Am J Cardiol
.
1999
;
83
:
1170
4
. .
23.
Hill
JM
,
Zalos
G
,
Halcox
JP
,
Schenke
WH
,
Waclawiw
MA
,
Quyyumi
AA
,
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
.
N Engl J Med
.
2003
;
348
:
593
600
. .
24.
Choi
JH
,
Kim
KL
,
Huh
W
,
Kim
B
,
Byun
J
,
Suh
W
,
Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure
.
Arterioscler Thromb Vasc Biol
.
2004
;
24
:
1246
52
. .
25.
Chen
JZ
,
Zhang
FR
,
Tao
QM
,
Wang
XX
,
Zhu
JH
,
Zhu
JH
.
Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia
.
Clin Sci
.
2004
;
107
:
273
80
. .
26.
Fadini
GP
,
Miorin
M
,
Facco
M
,
Bonamico
S
,
Baesso
I
,
Grego
F
,
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus
.
J Am Coll Cardiol
.
2005
;
45
:
1449
57
. .
27.
Notohamiprodjo
M
,
Andrassy
K
,
Bommer
J
,
Ritz
E
.
Dialysis membranes and coagulation system
.
Blood Purif
.
1986
;
4
:
130
41
. .
28.
Leon
MB
,
Mauri
L
,
Popma
JJ
,
Cutlip
DE
,
Nikolsky
E
,
O'Shaughnessy
C
,
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
.
J Am Coll Cardiol
.
2010
;
55
:
543
54
. .
29.
Park
KW
,
Chae
IH
,
Lim
DS
,
Han
KR
,
Yang
HM
,
Lee
HY
,
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/promus versus cypher to reduce late loss after stenting) randomized trial
.
J Am Coll Cardiol
.
2011
;
58
:
1844
54
. .
30.
Ahn
JM
,
Park
DW
,
Kim
YH
,
Song
H
,
Cho
YR
,
Kim
WJ
,
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial
.
Circ Cardiovasc Interv
.
2012
;
5
:
633
40
. .
31.
Bhatt
DL
,
Eagle
KA
,
Ohman
EM
,
Hirsch
AT
,
Goto
S
,
Mahoney
EM
,
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis
.
JAMA
.
2010
;
304
:
1350
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.